Kriyatx
kriyatx.com
Actively hiring
Business Travel
Cell & Gene Therapy
Hospitals & Health Systems
View 1 job
Follow
Overview
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$870.3M
4 rounds on record
Latest round
$320.8M
Venture round · Jul 2025 · 14 mo ago
Team
179
US Form 5500 (plan participants) · Dec 2024
Hiring now
2
+2 posted in 30 days
Backers
1
Foresite Capital
The money's age
Due for its next round
14 months since the last round · and hiring
Momentum
27/100
hiring for its size
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 31, 2025
Raised a round Venture round $320.8M · SEC Form D
May 10, 2022
Raised a round Venture round $361.8M · SEC Form D
Jun 30, 2021
Raised a round Venture round $100M · SEC Form D
May 4, 2020
Raised a round Venture round $87.6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2025 | $320.8M | — | SEC Form D |
| Venture round | May 2022 | $361.8M | — | SEC Form D |
| Venture round | Jun 2021 | $100M | — | SEC Form D |
| Venture round | May 2020 | $87.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Kriya Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Shankar RamaswamyExecutive Officer, DirectorSEC Form D
Daniel ChenExecutive OfficerSEC Form D
Dana JohnsonExecutive OfficerSEC Form D
Neera RavindranExecutive OfficerSEC Form D
Ilise LombardoExecutive OfficerSEC Form D
Britt PettyExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital Similar startupsby what they do, their industry and backers
About Us We build the medicines we wish existed CPTx is a genetic medicines company redefining how we treat disease using immune-silent…
Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable…
Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.
Developing scalable in-vivo genomic medicine for blood disorders.
A gene therapy approach to treating chronic, age-related disease. Targeting the root causes of aging to create life-changing treatments for…
At cellvie, we are pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism.
People
Shankar Ramaswamy
Executive Officer, Director
Daniel Chen
Executive Officer
Dana Johnson
Executive Officer
Neera Ravindran
Executive Officer
Ilise Lombardo
Executive Officer
Britt Petty
Executive Officer
Michele Stone
Executive Officer
Curt Herberts
Executive Officer
Katherine Eade
Executive Officer
Brian Furmanski
Executive Officer
C.r. Sincock
Director
Roger Jeffs
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
56/100
Growing
Open positions
1
2 opened / 0 closed in 30 days
Median time-to-fill
6 days
faster than 75% of the market
ATS activity
Every ~10 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
50% ▲
Operations
50% ▲
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Palo Alto
United States
HQ
Durham
United States
Regional office
Kriya Therapeutics
Park
United States
Engineering / R&D
Research Triangle Park
1219 Shiloh Glenn Drive, Durham, NC 27703
Jobs
Apply
Financials
Total raised
$870.3M
Latest round
Venture - Series Unknown
Funding rounds
4